Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/1992
11/10/1992US5162339 Substance P Antagonists, Gastrointestinal and Central Nervous System Disorders, Antiinflammatory Agents, Analgesics
11/10/1992US5162323 Inhibition of the withdrawal syndrome
11/10/1992US5162312 11β-substituted 16α, 17α-methylene-estra-4,9-dien-3-ones
11/10/1992US5162311 Treating epilepsy, psychiatric disorders
11/10/1992CA2067567A1 Compounds
11/10/1992CA2067537A1 Compounds
11/10/1992CA1310020C 1-aminophenyl-2-dimethylaminopropanone derivatives, method of preparation and use in therapy
11/08/1992CA2063895A1 Angiotensin ii antagonists incorporating a substituted thiophene or furan
11/05/1992DE4113984A1 Salze der 4-hydroxy-buttersaeure Salts of 4-hydroxy-butyric acid
11/04/1992WO1992019605A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/04/1992EP0511943A2 Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same
11/04/1992EP0511816A2 Neurotrophic peptide derivative
11/04/1992EP0511610A1 Benzisothiazole- and benzisoxazole-3-carboxamides, a process for their preparation and their use as antipsychotic medicaments
11/04/1992CN1065866A Prodrug esters of phenolic 2-piperidino-1-alkanols
11/04/1992CN1065865A Indole and dihydroquinoline potassium channel openers
11/04/1992CA2108902A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
11/04/1992CA2067834A1 Dialkylenepiperidino compounds and their enantiomers, process for preparing them and pharmaceutical compositions containing them
11/03/1992CA2067648A1 Octahydrobenzo[g]quinoline
11/03/1992CA1309659C Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration
10/1992
10/30/1992WO1992019621A1 Pcp receptor ligands and the use thereof
10/30/1992CA2109420A1 Pcp receptor ligands and the use thereof
10/29/1992WO1992018627A1 Glial mitogenic factors, their preparation and use
10/29/1992WO1992018493A1 Benzopyranones, methods of manufacture and use thereof
10/29/1992WO1992018489A1 Arylmorpholine, preparation and use
10/29/1992WO1992018475A2 Substituted phenylazacycloalkanes as cns agents
10/29/1992WO1992018461A1 Ethanolamine derivatives with anti-pollakiuria activity
10/29/1992WO1992018140A1 Activity-dependent neurotrophic factor
10/29/1992WO1992018121A1 Thiocarbamate sulfoxide composition for deterring ethanol ingestion
10/29/1992WO1992018112A1 Method of preventing nmda receptor complex-mediated neuronal damage
10/29/1992DE4114397A1 (beta)-carbolin-3- hydroxyalkylcarbonsaeureestrderivate, verfahren zu deren herstellung und deren verwendung in arzneimitteln (Beta) carboline-3- hydroxyalkylcarbonsaeureestrderivate, processes for their preparation and their use in medicaments
10/29/1992DE4113820A1 Verwendung von torasemid zur behandlung von hirnoedemen Use of torasemide for the treatment of cerebral edema
10/29/1992CA2108174A1 Benzopyranones, methods of manufacture and use thereof
10/28/1992WO1992019619A1 β-CARBOLIN-3-HYDROXYALKYL CARBOXYLIC ACID ESTER DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN MEDICAMENTS
10/28/1992EP0511188A2 Novel binding peptides
10/28/1992EP0511168A1 Indoline hydrochloride salts and process for their preparation
10/28/1992EP0511073A1 Antiserotonines, their preparation and medicaments containing them
10/28/1992EP0511031A1 3-Aryl-oxazolidinon derivatives, process for their preparation and their use in therapeutics
10/28/1992EP0510837A2 Synergistic combinations in the treatment of anxiety
10/28/1992EP0510489A1 Use of R(+)-3-amino-1-hydroxy-pyrrolidin-2-one for treating anxiety
10/28/1992EP0510398A2 N-Imidazolyl derivatives of substituted indole
10/28/1992EP0510333A1 Substituted oxotremorine derivatives
10/28/1992EP0510186A1 Therapeutic uses of melanin
10/28/1992EP0510129A1 Muscarinic receptor antagonists
10/28/1992EP0510068A1 NEW CENTRALLY ACTING 6,7,8,9-TETRAHYDRO-3H-BENZ(e)INDOLE HETEROCYCLICS
10/28/1992EP0345304B1 Pharmaceutical compositions
10/28/1992EP0221958B1 3-aminopropyloxyphenyl derivatives their preparation and pharmaceutical compositions containing them
10/28/1992CN1018827B Calcium independent camp phosphodiesterase inhibitor antidepressant
10/28/1992CA2086340A1 .beta.-carboline-3-hydroxyalkycarboxylic acid ester derivatives, proce ss for their production and their use in pharmaceutical agents
10/28/1992CA2067039A1 Neurotrophic peptide derivatives
10/27/1992WO1992019624A1 Antiserotonines, prepartion thereof and medicaments containing them
10/27/1992WO1992019234A2 Method of treating/preventing substance abuse using 1-alkyl-5(substituted oxy)-2-aminotetralins
10/27/1992US5159083 Treatment of schizophrenia, depression, parkinson's disease; side effect reduction
10/27/1992US5159081 Intermediates of peripherally selective n-carbonyl-3,4,4-trisubstituted piperidine opioid antagonists
10/27/1992US5158970 Proline derivatives
10/27/1992US5158957 2-substituted ergolines
10/27/1992US5158947 Condensed heterocyclic compounds and psychopharmaceutical composition containing same
10/27/1992US5158771 Nicotine compositions
10/27/1992CA2106197A1 Method of treating/preventing substance abuse
10/27/1992CA2103562A1 Antiserotonins, preparation thereof and medicaments containing them
10/27/1992CA2067040A1 Indoline hydrochloride salts and process for their preparation
10/27/1992CA2066834A1 Use of glycine/nmda receptor ligands for the treatment of drug dependence and withdrawal
10/27/1992CA1309406C Cinnoline compounds
10/25/1992WO1992019254A1 α-SUBSTITUTED POLYPEPTIDES HAVING THERAPEUTIC ACTIVITY
10/25/1992CA2106764A1 Ó-substituted polypeptides having therapeutic activity
10/25/1992CA2066938A1 N-imidazolyl derivatives of substituted indole
10/25/1992CA2066856A1 Substituted oxotremorine derivatives
10/23/1992CA2066468A1 Use of r(+)-3-amino-1-hydroxy-pyrrolidin-2-one for treating anxiety
10/22/1992DE4112353A1 1,3,4-trisubstituierte piperidin-derivate, ihre herstellung und verwendung 1,3,4-tri-substituted piperidine derivatives, their preparation and use
10/21/1992EP0509762A1 Indole and dihydroquinoline potassium channel openers
10/21/1992EP0509402A1 Substituted 3-(Pyridinylamino)-indoles and benzo[b]thiophenes, a process for their preparation and their use as medicaments
10/21/1992EP0509400A1 1-(Pyrido[3,4-b]-1,4-oxazinyl-4-yl)-1H-indoles, intermediates and a process for their preparation, and their use as medicaments
10/21/1992EP0509033A1 4,4'- 9h-fluoren-9-ylidenebis(methylene)]-bispyrimidine for treating neurological disorders
10/21/1992CN1065460A Nonsaditive antihistaminics derived from benzimidazoles
10/21/1992CN1065459A Piperidine derivatives and process for them and use in therapy
10/21/1992CN1065455A Piperiding derivatives
10/20/1992WO1992018156A1 Bradykinin antagonist peptides
10/20/1992WO1992018155A1 Bradykinin type peptides
10/20/1992US5157140 Esters of myo-inositol phosphate
10/20/1992US5157040 Substituted quinolines as angiotensin ii antagonists
10/20/1992US5157038 Antidepressants; tranquilizers; treatment of schizophrenia and epilepsy; antilepmic agents
10/20/1992US5157034 Neuroleptic perhydro-1H-pyrido[1,2-a]pyrazines
10/20/1992US5156601 Blend of polyurethane and decyclized poly(N-vinyl lactam)
10/19/1992WO1992018502A1 Prodrug esters of phenolic 2-piperidino-1-alkanols
10/19/1992WO1992018003A1 Inhibitors of kynureninase
10/19/1992CA2108670A1 Inhibitors of kynureninase
10/19/1992CA2108557A1 Prodrug esters of phenolic 2-piperidino-1-alkanols
10/17/1992WO1992018480A1 1,3,4-trisubstituted piperidine derivatives, their production and use
10/17/1992CA2107665A1 1,3,4-trisubstituted piperidine derivatives, the preparation and use thereof
10/17/1992CA2065962A1 3-aryl oxazolidinone derivatives, a method of preparing them and therapeutic use thereof
10/16/1992WO1992018127A1 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
10/16/1992WO1992018114A1 Nabumetone powders
10/16/1992CA2108480A1 Use of sigma receptor antagonists to enhance the effects of antipsychotic drugs
10/16/1992CA2108379A1 Nabumetone powders
10/16/1992CA2065499A1 Indole and dihydroquinoline potassium channel openers
10/15/1992WO1992017475A1 Heterocyclic-cyclic amine derivatives
10/15/1992WO1992017473A1 Crystalline tiagabine hydrochloride monohydrate, its preparation and use
10/15/1992WO1992017169A1 Use of deprenyl to maintain, prevent loss, or recover nerve cell function
10/15/1992DE4111861A1 Benzopyranone, verfahren zu ihrer herstellung und verwendung Benzopyranones, processes for their preparation and use
10/14/1992EP0508799A1 Cholecystokinin antagonists
10/14/1992EP0508798A1 Cholecystokinin antagonists
1 ... 1714 1715 1716 1717 1718 1719 1720 1721 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 ... 1833